Food and Drug Administration FDA has announced that it had approved nationwide trials of convalescent plasma and hyper immune globulin treatments in the fight against pandemic virus. Both the treatment is related to blood plasma of those people who are recovered from this deadly virus.  It means to make antibodies that the human immune system makes to fight off germs. FDA commissioner Stephen Hahn announced the trials by saying, ’this is an important area of research the use of products made from a recovered patient’s blood to potentially treat COVID-19’.

PLASMA TRANSFUSION IN CORONAVIRUS COVID-19
Ruheen Salam
Ruheen Salam

PLASMA TRANSFUSION IN CORONAVIRUS COVID-19

Food and Drug Administration FDA has announced that it had approved nationwide trials of convalescent plasma and hyper immune globulin treatments in the fight against pandemic virus. Both the treatment is related to blood plasma of those people who are recovered from this deadly virus.  It means to make antibodies that the human immune system makes to fight off germs. FDA commissioner Stephen Hahn announced the trials by saying, ’this is an important area of research the use of products made from a recovered patient’s blood to potentially treat COVID-19’.

Using blood products from a disease worrier’s body is an ancient treatment to fight against polio first, later in 1918 two physicians in Naval the hospital tried this in people effected by pneumonia as a result of influenza. The result was great.

Using blood products from a disease worrier’s body is an ancient treatment to fight against polio first

According to Darrell Triulzi director of the division of transfusion medicine at the University of Pittsburgh Medical Centre,’ The initial steps are to follow individuals who have recovered and had a way to measure their antibody response’.

Pakistani scientists are eagerly waiting for the approval of clinical trials of plasma transfusion. A research team of Dow Medical Sciences has devised intravenous immunoglobulin with plasma obtained from the blood of recovered patients from COVID-19. The plasma with antibodies was donated by Yahya Jaffery the very first recovered patient. The lab tests and animal trails are gone successful. The initial trial is going to start soon as approval has come.

The plasma with antibodies was donated by Yahya Jaffery the very first recovered patient

Turkey, France and U.S. have also started their trials, but according to Pakistani doctors and scientists, IVIG is a more effective treatment. Since March 28 critically ill 11 patients in New York and Houston became the first in the U.S. to start a promising experimental treatment. In china 5 critically ill patients, who were on mechanical ventilation received convalescent plasma 10-22 days after being admitted to a hospital. In March 25 three of them has been discharged and after 50 days other two came in stable condition.

According to Jeffrey P Henderson Associate Professor of Medicine and Molecular Biology in the division of infectious disease, ’But as the disease progresses, the tissue damage was done by a virus is more difficult to reverse and isn’t necessarily reversed by something that is solely targeted towards the virus itself’. It doesn’t mean that this therapy isn’t useful. He further says,’ we have so much to learn, of course, but we are thinking the antibodies may prevent the virus from expending its numbers’.

Turkey, France and U.S. have also started their trials, but according to Pakistani doctors and scientists, IVIG is a more effective treatment. Since March 28 critically ill 11 patients in New York and Houston became the first in the U.S. to start a promising experimental treatment. In china 5 critically ill patients, who were on mechanical ventilation received convalescent plasma 10-22 days after being admitted to a hospital. In March 25 three of them has been discharged and after 50 days other two came in stable condition.

According to Jeffrey P Henderson Associate Professor of Medicine and Molecular Biology in the division of infectious disease, ’But as the disease progresses, the tissue damage was done by a virus is more difficult to reverse and isn’t necessarily reversed by something that is solely targeted towards the virus itself’. It doesn’t mean that this therapy isn’t useful. He further says,’ we have so much to learn, of course, but we are thinking the antibodies may prevent the virus from expending its numbers’.
%d bloggers like this: